Covid Report: Gilead Nears Coronavirus Data In 'Weeks'; J&J Bullish On VaccineInvestors Business Daily • 03/30/20
Gilead Asks the FDA to Rescind Orphan Drug Designation for Remdesivir as a Treatment for COVID-19The Motley Fool • 03/25/20
Covid Report: Gilead Asks FDA To Rescind Key Status For Coronavirus DrugInvestors Business Daily • 03/25/20